Literature DB >> 30624715

Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis.

Luca Segreti1, Christopher A Rinaldi2, Simon Claridge2, Jesper Hastrup Svendsen3, Carina Blomstrom-Lundqvist4, Angelo Auricchio5, Christian Butter6, Nikolaos Dagres7, Jean-Claude Deharo8, Aldo P Maggioni9,10, Andrzej Kutarski11, Charles Kennergren12, Cecile Laroche10, Maciej Kempa13, Andrea Magnani14, Benjamin Casteigt15, Maria Grazia Bongiorni16.   

Abstract

AIMS: The decision to abandon or extract superfluous leads remains controversial. We sought to compare procedural outcome of patients with and without abandoned leads undergoing transvenous lead extraction (TLE). METHODS AND
RESULTS: An analysis of the ESC-EHRA European Lead Extraction ConTRolled ELECTRa registry was conducted. Patients were stratified into two groups based on the presence (Group 1) or absence (Group 2) of abandoned leads at the time for extraction. Out of 3508 TLE procedures, 422 patients (12.0%) had abandoned leads (Group 1). Group 1 patients were older and more likely to have implantable cardioverter-defibrillator devices, infection indication (78.8% vs. 49.8%), and vegetations (24.6% vs. 15.3%). Oldest lead dwelling time was longer in Group 1 (10.9 vs. 6.3 years) as was the number of extracted leads per patient (3.2 vs. 1.7). Manual traction failure (94.5% vs. 78.8%), powered sheath use (50.7% vs. 28.4%), and femoral approach were higher in Group 1 (P < 0.0001). Procedural success rate and clinical success (89.8% vs. 96.6%, P < 0.0001) were lower in Group 1. Major complication including deaths (5.5% vs. 2.3%, P = 0.0007) and procedure related major complications (3.3% vs. 1.4%, P = 0.0123) were higher in Group 1. The presence of abandoned leads at the time of TLE was an independent predictor of clinical failure [odds ratio (OR) 2.31, confidence interval (CI) 1.57-3.40] and complications [OR 1.69, CI 1.22-2.35]. receiver-operating characteristic curve analysis showed a dwell time threshold of 9 years for radiological failure and major complications.
CONCLUSIONS: Previously abandoned leads at the time of TLE were associated with increased procedural complexity, clinical failure, and major complication, which may have important implications for future studies regarding managing of lead failures. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Abandoned leads; Extraction outcome; Lead extraction

Year:  2019        PMID: 30624715     DOI: 10.1093/europace/euy307

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

1.  The prognostic value of transesophageal echocardiography after transvenous lead extraction: landscape after battle.

Authors:  Dorota Nowosielecka; Wojciech Jacheć; Anna Polewczyk; Andrzej Kleinrok; Łukasz Tułecki; Andrzej Kutarski
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

2.  Strategies to increase the INGEVITY lead strength during lead extraction procedures based on laboratory bench testing.

Authors:  Pierce Vatterott; Andrew De Kock; Eric F Hammill; Robert Lewis
Journal:  Pacing Clin Electrophysiol       Date:  2021-07-21       Impact factor: 1.912

3.  Prognostic Value of Preoperative Echocardiographic Findings in Patients Undergoing Transvenous Lead Extraction.

Authors:  Dorota Nowosielecka; Wojciech Jacheć; Anna Polewczyk; Łukasz Tułecki; Andrzej Kleinrok; Andrzej Kutarski
Journal:  Int J Environ Res Public Health       Date:  2021-02-14       Impact factor: 3.390

4.  Reducing CIED-Related Morbidity: "LESS Is More".

Authors:  François D Regoli
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

5.  Step by Step through the Years-High vs. Low Energy Lead Extraction Using Advanced Extraction Techniques.

Authors:  David Zweiker; Basma El Sawaf; Giuseppe D'Angelo; Andrea Radinovic; Alessandra Marzi; Luca R Limite; Antonio Frontera; Gabriele Paglino; Michael Spartalis; Donah Zachariah; Kenzaburo Nakajima; Paolo Della Bella; Patrizio Mazzone
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.